Renal CT after intravenous injection of nonionic dimeric or nonionic monomeric contrast media in healthy volunteers

Acta Radiologica

Volumn 38, Issue 1, 1997, Pages 61-67

  Rasmussen, Finn ^a,c   Lindequist, S ^a   Moller Nielsen S ^a   Bjartveit, K ^b  

^a University of Esbjerg   (Denmark)

^b Nycomed Denmark   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Comparative studies; Contrast media, time density curves; CT, renal

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; IOHEXOL; IOPROMIDE;

ABDOMINAL AORTA; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFERIOR CAVA VEIN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; METHODOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; STATISTICS; TIME;

ADULT; AORTA, ABDOMINAL; CONTRAST MEDIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; IOHEXOL; KIDNEY; MALE; REFERENCE VALUES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS; VENA CAVA, INFERIOR;

EID: 0030637402     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859709171243     Document Type: Article

References (36)

1. ANDREW E.: Personal communication.
2. BENNESS G., EVILL C., WILCOX J., HASSANN R. & AROZOO E.: Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs. In: Recent developments in nonionic contrast media, p. 88. Edited by V. Taenzer & S. Wende. Thieme Verlag, Stuttgart 1989.
3. BJÖRK L. & ZACHRISSON B. F.: Low dose urography with a low dose osmolar contrast medium. Acta Radiol. 27 (1986), 111.
4. BRENNAN R. E., CURTIS J. A., POLLACK H. M. & WEINBERG I.: Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. II. The renal medulla. Invest. Radiol. 14 (1979), 239.
5. BRENNAN R. E., RAPOPORT S., WEINBERG I., POLLACK H. M. & CURTIS J. A.: CT-determined canine kidney and urine iodine concentration following intravenous administration of sodium diatrizoate, metrizamide, iopamidol, and sodium ioxaglate. Invest. Radiol. 17 (1982), 95.
6. CONROY R. M., BJARTVEIT K., SHEPPICK A., LONG U. & MASTERSON J.: Iodixanol in intravenous urography. A comparison of iodixanol 270 mg I/ml, iodixanol 320 mg I/ml and iopamidol 300 mg I/ml (Niopam). Clin. Radiol. 49 (1994), 337.
7. DAWSON P.: The non-ionic dimers - some theoretical and clinical considerations. Eur. J. Radiol. (1995), Suppl. 5, S103.
8. DAWSON P., HERON C. & MARSHALL J.: Intravenous urography with low osmolality contrast agents. Theoretical considerations and clinical findings. Clin. Radiol. 35 (1984), 173.
9. DORPH S., SOVAK M., TALNER L. B. & ROSEN L.: Why does kidney size change during i.v. urography? Invest. Radiol. 12 (1977), 246.
10. DRAY R. J., WINFIELD A. C., MUHLETALER C. A. & KIRCHNER F. K.: Advantages of non-ionic contrast agents in adult urography. Urologe 24 (1984), 297.
11. EKELUND L.: Iohexol in urography. Acta Radiol. (1983), Suppl. 386, S25.
12. EVILL C. A., WILCOX J., HASSANN R. M., BENNESS G. T. & AROZOO E.: Examination of the nephrographic potential of iotrol by computed tomography. In: Recent developments in nonionic contrast media, p. 216. Edited by V. Taenzer & S. Wende. Thieme Verlag, Stuttgart 1989.
13. HOLTZ E. & GOLMAN K.: Experimental urography with new non-ionic dimeric and monomeric contrast agents. Acta Radiol. (1987), Suppl. 370, p. 49.
14. JACOBSEN J. Å., LUNDBY B., KRISTOFFERSEN D. T., BORCH K. W., HALD J. K. & BERG K. J.: Evaluation of renal function with delayed CT after injection of non-ionic monomeric and dimeric contrast media in healthy volunteers. Radiology 182 (1992), 419.
15. JACOBSEN P. B., BLINDHEIM L. & SKOTLAND T.: Bioanalytical methods for iodixanol and their application to studies on metabolism and protein binding. Acta Radiol. (1995), Suppl. 399, p. 61.
16. JACOBSSON B. F., JORULF H., KALANTAR M. S. & NARASHUHAM D. L.: Nonionic versus ionic contrast media in intravenous urography. Clinical trial in 1000 consecutive patients. Radiology 167 (1988), 601.
17. KATAYAMA H., YAMAGUCHI K., KOZUKA T., TAKASHIMA T, SEEZ P. & MATSUURA K.: Adverse reactions to ionic and nonionic contrast media. Radiology 175 (1990), 621.
18. KATZBERG R. W.: Renal effects of contrast media. Invest. Radiol. (1988), Suppl. 1, S157.
19. KORMANO M., PARTANEN K., SOIMAKALLIO S. & KIVIMÄKI T.: Dynamic contrast enhancement of the upper abdomen. Effect of contrast media and body weight. Invest. Radiol. 18 (1983), 364.
20. LEVI C., GRAY J. E., MCCULLOGH E. C. & HATTERY R. R.: The unreliability of CT-numbers as absolute values. AJR 139 (1982), 443.
21. LORUSSO V., POGESSI V. & TIRONE P.: Protein binding of iodinated contrast agents. Br. J. Radiol. 63 (1990), 987.
22. MAGILL H. L., CLARKE E. A., FITCH S. J. et al.: Excretory urography with iohexol. Evaluation in children. Radiology 161 (1986), 625.
23. MCCULLOUGH M., DAVIES P. & RICHARDSON R.: A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. Br. J. Radiol. 62 (1989), 260.
24. NARIMATSU Y. & HIRAMATSU K.: A Japanese multicenter comparison of iotrolan 280 with iopamidol 300 in intravenous urography. Eur. J. Radiol. (1995), Suppl. 2, S58.
25. NAURT C. & MÜTZEL W.: Experimental urography in dogs. Diagnostic quality and pharmacokinetic behaviour of iotrolan in comparison to nonionic and ionic, monomeric contrast media, p. 82. In: Recent developments in nonionic contrast media. Edited by V. Taenzer & S. Wende. Thieme Verlag, Stuttgart 1989.
26. NOSSEN J. Ø., BACH-GANSMO T., KLOSTER Y. & JØRGENSEN N. P.: Heat sensation in connection with intravenous injection of isotonic and low-osmolar x-ray contrast media and mannitol solutions. Eur. J. Radiol. 3 (1993), 46.
27. RANKIN R. W. & EVY F. W. H. T.: Iohexol vs diatrizoate. A comparative study in intravenous urography. Invest. Radiol. (1985), Suppl. 20, S112.
28. SILVAY-MANDEAU O. M., MEISSNER C. & WENZEL-HORA B. I.: Clinical safety assessment of iotrolan 280 in European clinical studies. Eur. J. Radiol. (1995), Suppl. 2, S85.
29. SJÖBERG S., ALMÉN T. & GOLMAN K.: Excretion of urographic contrast media. I. Iohexol and other media during free urine flow in the rabbit. Acta Radiol. (1980), Suppl. 362, S93.
30. SJÖBERG S., GOLMAN K. & ALMÉN T.: Excretion of urographic contrast media. II. Iohexol and sodium diatrizoate during ureteric stasis in the rabbit. Acta Radiol. (1980), Suppl. 362, S99.
31. SPATARO R. F., FISCHER H. W. & BOYLAN L.: Urography with low osmolality contrast media. Comparative urinary excretion of iopamidol, Hexabrix and diatrizoate. Invest. Radiol. 17 (1982), 492.
32. SVALAND M. G., HAIDER T., LANGSETH-MAURIQUE K., ANDREW E. & HALS P. A.: Human pharmacokinetics of iodixanol. Invest. Radiol. 27 (1992), 130.
33. TAENZER V., HEEP H. & CLAUSS W.: Urography with non-ionic contrast media. I. Diagnostic quality and tolerance of iohexol in comparison with meglumine amidotrizoate. RÖFO 118 (1983), 146.
34. TSUGAYA M., SAKAGAMI H., MOGAMI T. & OHTAGURO K.: Administration and dosage of iohexol, a non-ionic contrast medium for dynamic renal computed tomography. Acta Urol. Jpn. 39 (1993), 687.
35. WINFIELD A. C., DRAY R. J., KIRCHNER F. K. JR, MUHLETALER C. A. & PRICE R. R.: Iohexol for excretory urography. A comparative study. AJR 141 (1983), 571.
36. YOSHIKAWA H.: Late adverse reactions to nonionic contrast media. Radiology 183 (1992), 737.